Cellbricks
Cellbricks Therapeutics is a biotech company pioneering regenerative medicine and longevity through deeptech innovation. It develops scalable, implantable tissue grafts using proprietary biofabrication technology, advanced biomaterials, and human cells to restore tissue and organ function. The company aims to transform healthcare by providing reliable, scalable, and immune-compatible tissue therapeutics.
Industries
Nr. of Employees
small (1-50)
Cellbricks
Müllerstraße 178, 13353 Berlin, Germany
Patents
3D scaffold comprising a biocompatible polymer with a colonization chamber open at the top for biological cells, and with a canal vessel surrounding the colonization chamber
US-12201982-B2
View DetailsMethod for producing 3D, biocompatible polymer scaffold with a cell-filled cavity
US-11993767-B2
View Details
3D scaffold comprising a biocompatible polymer with a colonization chamber open at the top for biological cells, and with a canal vessel surrounding the colonization chamber
US-12201982-B2
View DetailsMethod for producing 3D, biocompatible polymer scaffold with a cell-filled cavity
US-11993767-B2
View DetailsProducts
Preclinical soft tissue therapeutic (adipose graft)
Biofabricated adipose tissue grafts designed to fill and heal deep complex wounds; in vivo preclinical data show host integration, rapid vascularization and absence of fibrosis in mouse models.
Preclinical liver tissue therapeutic
Biofabricated metabolically active liver tissue designed to restore liver function and potentially act as a bridge to transplantation; demonstrated sustained metabolic activity in preclinical studies.
Preclinical soft tissue therapeutic (adipose graft)
Biofabricated adipose tissue grafts designed to fill and heal deep complex wounds; in vivo preclinical data show host integration, rapid vascularization and absence of fibrosis in mouse models.
Preclinical liver tissue therapeutic
Biofabricated metabolically active liver tissue designed to restore liver function and potentially act as a bridge to transplantation; demonstrated sustained metabolic activity in preclinical studies.
Services
Collaborative program development and execution of preclinical studies, technology validation and translational planning with academic and clinical partners.
Collaborative program development and execution of preclinical studies, technology validation and translational planning with academic and clinical partners.
Expertise Areas
- Light-based biofabrication
- 3D bioprinting and tissue engineering
- Biomaterials and bioink formulation
- Vascularized tissue engineering
Key Technologies
- Light-based projection photopolymerization
- AI-driven tissue design and process control
- Tailor-made bioinks/hydrogel formulations
- Image recognition for inline quality control
News & Updates
Feature in ZDF discussing future business models in Germany.
Feature in Handelsblatt about successful animal trials of bioprinted organ tissue.
Press release about positive in vivo results in tissue and organ bioprinting.
Feature in ZDF discussing future business models in Germany.
Feature in Handelsblatt about successful animal trials of bioprinted organ tissue.
Press release about positive in vivo results in tissue and organ bioprinting.